| Zacks Company Profile for Terumo Corp. (TRUMY : OTC) |
|
|
| |
| • Company Description |
| Terumo Corporation is engaged in the manufacture and sales of medical products and equipment. The products offered by the Company covers General Hospital Products, Cardiac & Vascular Products, Blood Transfusion Products and Consumer Healthcare Products. General hospital products offered by it include Disposable Medical Equipment, Medical Electronic Products, Diabetes Care Products, CAPD Systems and Pharmaceuticals; Cardiac & Vascular Products include Interventional Systems, Cardiovascular Systems and Artificial Vascular Grafts. Terumo's Blood Transfusion products include blood bags, blood filter, filter in line, blood administration sets and apheresis, while consumer healthcare products include ear thermometer, electronic thermometer, basal body thermometer, electronic sphygmomanometer, urine test strip and leg compression stockings. Terumo Corporation is headquartered in Tokyo, Japan.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $31.23 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 109,442 shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $23,719.84 (millions) |
| Beta: 0.36 |
| 52 Week High: $50.53 |
| 52 Week Low: $28.15 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
3.65% |
13.11% |
| 12 Week |
-0.19% |
5.08% |
| Year To Date |
-27.69% |
-15.71% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Shinjiro Sato - Chief Executive Officer and President
Takayoshi Mimura - Chairman of the Board
Kyo Nishikawa - Senior Executive Officer and Director
Ikuo Mori - Director
Yukiko Kuroda - Director
|
|
Peer Information
Terumo Corp. (BJCT)
Terumo Corp. (CADMQ)
Terumo Corp. (APNO)
Terumo Corp. (UPDC)
Terumo Corp. (IMTIQ)
Terumo Corp. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 88156J105
SIC: 5047
|
|
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 05/18/22
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: 4.00 (2.00:1)
Beta: 0.36
Market Capitalization: $23,719.84 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.65% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.20 |
| Current Fiscal Year EPS Consensus Estimate: $1.32 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 05/18/22 |
|
|
|
| |
